AlphaQuest’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,075
Closed -$929K 2011
2025
Q4
$929K Sell
22,075
-1,884
-8% -$75.9K 0.05% 469
2025
Q3
$823K Buy
23,959
+15,928
+198% +$457K 0.05% 511
2025
Q2
$217K Buy
8,031
+7,449
+1,280% +$216K 0.02% 1077
2025
Q1
$17.3K Sell
582
-569
-49% -$21.7K ﹤0.01% 1723
2024
Q4
$45.6K Sell
1,151
-8,728
-88% -$330K 0.01% 1306
2024
Q3
$336K Sell
9,879
-10,701
-52% -$301K 0.03% 851
2024
Q2
$446K Buy
20,580
+5,223
+34% +$110K 0.06% 493
2024
Q1
$340K Sell
15,357
-4,840
-24% -$118K 0.06% 484
2023
Q4
$556K Buy
+20,197
New +$488K 0.12% 309

Other funds holding VCYT

AlphaQuest's VCYT Position: Q1 2026 in Review

AlphaQuest sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 22,075 shares — an estimated $929K sold.

AlphaQuest first reported a position in VCYT in Q4 2023 and held it in 9 quarters. The position peaked at $929K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • AlphaQuest reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 22,075 Veracyte shares in Q1 2026, an estimated $929K.
  • AlphaQuest first reported a position in Veracyte in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Veracyte position peaked at $929K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.